Anna Vaynrub
YOU?
Author Swipe
View article: The breast cancer genetic testing experience: probing the potential utility of an online decision aid in risk perception and decision making
The breast cancer genetic testing experience: probing the potential utility of an online decision aid in risk perception and decision making Open
View article: Predictors of trastuzumab-induced cardiotoxicity among racially and ethnically diverse patients with HER2-positive breast cancer
Predictors of trastuzumab-induced cardiotoxicity among racially and ethnically diverse patients with HER2-positive breast cancer Open
TIC was more common among NHB compared to NHW, however, Black race was not consistently associated with TIC after adjustment for CVD risk factors. This suggests that CVD comorbidities (e.g., hypertension) that more frequently affect racial…
View article: Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904)
Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904) Open
View article: Feasibility of veno-arterial extracorporeal life support in awake patients with cardiogenic shock
Feasibility of veno-arterial extracorporeal life support in awake patients with cardiogenic shock Open
OBJECTIVES This study sought to demonstrate outcomes of veno-arterial extracorporeal life support (VA-ECLS) in non-intubated (‘awake’) patients with cardiogenic shock, as very few studies have investigated safety and feasibility in this po…
View article: Factors Driving Patient Decisions to Access Electronic Health Records via a Breast Cancer Online Decision Aid linked to the Patient Portal.
Factors Driving Patient Decisions to Access Electronic Health Records via a Breast Cancer Online Decision Aid linked to the Patient Portal. Open
A critical strategy in limiting breast cancer (BC) mortality is the early identification of high-risk patients and implementation of risk-reducing measures. RealRisks, an online decision aid constructed by our team to provide educat…
View article: User Comprehension and EHR Integration of the <i>RealRisks</i> Decision Aid for Breast Cancer Risk Assessment: A Qualitative Study.
User Comprehension and EHR Integration of the <i>RealRisks</i> Decision Aid for Breast Cancer Risk Assessment: A Qualitative Study. Open
RealRisks is a decision aid that integrates patient-generated and electronic health record (EHR) data using Fast Healthcare Interoperability Resources (FHIR). It offers modules to enhance understanding of breast cancer risk and a way for i…
View article: Use of Veno-Arterial Extracorporeal Life Support (VA ECLS) in Awake Patients in Refractory Cardiogenic Shock
Use of Veno-Arterial Extracorporeal Life Support (VA ECLS) in Awake Patients in Refractory Cardiogenic Shock Open
View article: Acute Kidney Injury During Extracorporeal Life Support in Cardiogenic Shock: Does Flow Matter?
Acute Kidney Injury During Extracorporeal Life Support in Cardiogenic Shock: Does Flow Matter? Open
View article: Pexidartinib in the Management of Advanced Tenosynovial Giant Cell Tumor: Focus on Patient Selection and Special Considerations
Pexidartinib in the Management of Advanced Tenosynovial Giant Cell Tumor: Focus on Patient Selection and Special Considerations Open
Anna Vaynrub,1 John H Healey,2 William Tap,3 Max Vaynrub2 1Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA; 2Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; 3Department of…
View article: Myo-Inositol Levels Measured with MR Spectroscopy Can Help Predict Failure of Antiangiogenic Treatment in Recurrent Glioblastoma
Myo-Inositol Levels Measured with MR Spectroscopy Can Help Predict Failure of Antiangiogenic Treatment in Recurrent Glioblastoma Open
Background Patients with recurrent glioblastoma (GBM) are often treated with antiangiogenic agents, such as bevacizumab (BEV). Despite therapeutic promise, conventional MRI methods fail to help determine which patients may not benefit from…
View article: BIOM-09. MYO-INOSITOL LEVELS ON MR SPECTROSCOPY CAN PREDICT FAILURE OF ANTI-ANGIOGENIC TREATMENT IN RECURRENT GLIOBLASTOMA
BIOM-09. MYO-INOSITOL LEVELS ON MR SPECTROSCOPY CAN PREDICT FAILURE OF ANTI-ANGIOGENIC TREATMENT IN RECURRENT GLIOBLASTOMA Open
BACKGROUND Recurrent glioblastoma (rGBM) patients are often treated with anti-angiogenic agents such as bevacizumab (BEV). Despite therapeutic promise, conventional MR methods fail to determine which patients may not benefit. PURPOSE: The …
View article: TAMI-29. MR SPECTROSCOPY MEASURES OF LAC/NAA AND NAA/CHO DIFFERENTIATE SURVIVORSHIP IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED WITH ANTI-ANGIOGENIC THERAPY
TAMI-29. MR SPECTROSCOPY MEASURES OF LAC/NAA AND NAA/CHO DIFFERENTIATE SURVIVORSHIP IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED WITH ANTI-ANGIOGENIC THERAPY Open
Patients with recurrent glioblastoma (rGBM) are often started on anti-angiogenic therapy such as bevacizumab. However, determining treatment failure using conventional MRI methods remains challenging. We prospectively collected longitudina…
View article: MR spectroscopic imaging predicts early response to anti-angiogenic therapy in recurrent glioblastoma
MR spectroscopic imaging predicts early response to anti-angiogenic therapy in recurrent glioblastoma Open
Background Determining failure to anti-angiogenic therapy in recurrent glioblastoma (GBM) (rGBM) remains a challenge. The purpose of the study was to assess treatment response to bevacizumab-based therapy in patients with rGBM using MR spe…